Acquiring a Biotech Company? Follow Our Technical Due Diligence Checklist

When private equity (PE) firms prepare for an M&A transaction, due diligence assessments help mitigate risk and safeguard a successful integration. The due diligence process becomes even more critical when acquiring niche, highly technical companies like those that operate in the life sciences and biotech industries. While these transactions often lead to growth and value creation opportunities, they can pose serious consequences when they are not vetted correctly.

Due diligence requires technical knowledge, which is why it’s important for PE firms to enlist specialists in the target company’s field. These specialists can better facilitate the due diligence process by helping firms assess the rewards and industry-specific risks inherent to these acquisitions.

BDO created a due diligence checklist for PE firms to help inform their decision-making and identify potential barriers. By enlisting an advisor to focus on technical due diligence, firms can ultimately focus on strategy and deal execution.

Technical Due Diligence Checklist

While every target acquisition company is different, especially considering the size of the business and the industry in which it operates, the following checklist outlines the common areas to consider when performing due diligence on a life sciences or biopharmaceutical company.

When executed correctly, due diligence covers a thorough examination of every facet of a target company's operations. By enlisting a technical due diligence professional, PE firms can feel more confident knowing they have a more accurate and complete understanding of the target company and its strengths, weaknesses, risks, and opportunities. For more information, visit our life sciences page.

Interested in how BDO uses technical due diligence assessments to help PE firms evaluate targets? Check out this case study.